Targeting hypoxia in head and neck cancer
- PMID: 11845958
- DOI: 10.1080/02841860152708215
Targeting hypoxia in head and neck cancer
Abstract
The idea of 'targeting' hypoxia stems from recognition of the fact that oxygen (or its lack) is central to the practice of radiation oncology. Targeting embraces the alternative goals of trying to overcome hypoxia on the one hand and trying to exploit it on the other. This presentation briefly reviews these two approaches with major emphasis on the latter.
Similar articles
-
Hypoxic sensitizer and cytotoxin for head and neck cancer.Ann Acad Med Singap. 1996 May;25(3):397-404. Ann Acad Med Singap. 1996. PMID: 8876907 Review.
-
Identifying and targeting hypoxia in head and neck cancer: a brief overview of current approaches.Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S56-8. doi: 10.1016/j.ijrobp.2007.04.081. Int J Radiat Oncol Biol Phys. 2007. PMID: 17848296 Free PMC article. No abstract available.
-
More lessons learned from the suffocation of hypoxia.J Clin Oncol. 2010 Jun 20;28(18):2941-3. doi: 10.1200/JCO.2010.28.3085. Epub 2010 May 17. J Clin Oncol. 2010. PMID: 20479396 No abstract available.
-
Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer.J Clin Oncol. 2001 Jan 15;19(2):535-42. doi: 10.1200/JCO.2001.19.2.535. J Clin Oncol. 2001. PMID: 11208848 Clinical Trial.
-
Tirapazamine: prototype for a novel class of therapeutic agents targeting tumor hypoxia.Semin Oncol. 2002 Feb;29(1 Suppl 4):102-9. doi: 10.1053/sonc.2002.31531. Semin Oncol. 2002. PMID: 11894020 Review.
Cited by
-
Hypoxia-induced autophagic response is associated with aggressive phenotype and elevated incidence of metastasis in orthotopic immunocompetent murine models of head and neck squamous cell carcinomas (HNSCC).Exp Mol Pathol. 2011 Apr;90(2):215-25. doi: 10.1016/j.yexmp.2010.11.011. Epub 2011 Jan 12. Exp Mol Pathol. 2011. PMID: 21236253 Free PMC article.
-
The potential roles of bacteria to improve radiation treatment outcome.Clin Transl Oncol. 2018 Feb;20(2):127-139. doi: 10.1007/s12094-017-1701-7. Epub 2017 Jun 16. Clin Transl Oncol. 2018. PMID: 28623514 Review.
-
Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer.Clin Cancer Res. 2006 Sep 15;12(18):5435-41. doi: 10.1158/1078-0432.CCR-05-1773. Clin Cancer Res. 2006. PMID: 17000677 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical